September 25, 2023
Plaintiffs in a class action against CVS Pharmacy Inc. over its labeling of lidocaine products are asking a New York federal court to award $1.1 million in attorney fees out of a $3.8 million settlement, saying attorneys' work and the scope of the settlement warrant the payout.
April 25, 2023
CVS and consumers have agreed to settle for $3.8 million in a New York federal class action over allegations that the pharmacy giant's lidocaine products didn't live up to promises of maximum strength and adhesion.